Research and Development

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …

GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …

OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …

GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …

 Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …

Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …

The only way that pressing needs in global public health can be met is for research to be shared more …

Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …

Spectrum Regulatory Solutions has appointed Dr Simon Thorn as a senior regulatory writer. He has more than 15 years experience …

The MHRA has reported it has RMS decentralised procedure slots available in 2011 for all therapeutic areas, including biologicals and …

The increasing number of SMEs in Europe is seen to be a driving force to facilitate economic growth, new product …

The MHRA has recently advised all holders of UK marketing authorisations, registrations and licences to inform them by the 31st …

The European Medicines Agency has published an updated report detailing the geographical origins of patients included in clinical trials for …

In April, we reported how a joint pilot scheme operated by the UK Medicines & Healthcare Products Regulatory Agency (MHRA), …